PALI - Palisade Bio Inc
IEX Last Trade
3.55
-0.050 -1.408%
Share volume: 4,044
Last Updated: Fri 30 Aug 2024 06:12:43 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.60
-0.05
-1.39%
Summary score
17%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
23%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2017 - 2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-38.55%
Return on assets
-27.03%
Return on sales
-76963.52%
Return on invested capital
-399.53%
Total debt ratio
25.3%
Debt ratio change over timeo
-1.01%
Current Ratio
8.18%
Quick Ratio
8.18%
Cash Position Ratio
7.36%
Short-term ratios 2020 - 2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.82%
Return on assets
-21.27%
Return on sales
-115801.09%
Return on invested capital
-92.55%
Total debt ratio
12.61%
Debt ratio change over timeo
-0.96%
Current Ratio
12.91%
Quick Ratio
12.91%
Cash Position Ratio
11.45%
Last quarter ratios 2021
The data are presented for the financials results of the last quarter.
Return on equity
-29.57%
Return on assets
-24.58%
Return on sales
0%
Return on invested capital
267.07%
Total debt ratio
13.31%
Debt ratio change over time
-1%
Current Ratio
8.63%
Quick Ratio
8.63%
Cash Position Ratio
6.46%
Performance ratios (change over 4 years) 2017 - 2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.12%
Return on assets
-102.32%
Return on sales
-7490.86%
Return on invested capital
317.1%
Total debt ratio
-100.9%
Debt ratio change over time
-1.01%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
-0.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PALI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -38.55% | -6.02% | 13.65% | 6.98% |
| Return on assets | -27.03% | 3.39% | 3.61% | 5.41% |
| Return on sales | -76963.52% | 30.6% | 40.46% | 35.45% |
| Return on invested capital | -399.53% | 4.76% | 7.3% | 15.54% |
| Profitability | 0% | 42% | 78% | 85% |
| Total debt ratio | 25.3% | 100.95% | 78.51% | 29.4% |
| Debt ratio change over time | -1.01% | 258.46% | 7.2% | 1.53% |
| Dept financing | 6% | 50% | 20% | 7% |
| Current Ratio | 12.91% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 12.91% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 11.45% | 0.29% | 0.88% | 1.14% |
| Liquididy | 75% | 10% | 21% | 26% |
| Short-term ratios | PALI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.82% | 8.95% | 17.54% | 9.49% |
| Return on assets | -21.27% | 2.19% | 3.45% | 5.63% |
| Return on sales | -115801.09% | 25.57% | 35.22% | 39.9% |
| Return on invested capital | -92.55% | 1.34% | 5.79% | 24.68% |
| Profitability | 0% | 40% | 68% | 89% |
| Total debt ratio | 12.61% | 90.54% | 84.19% | 35.66% |
| Debt ratio change over time | -0.96% | 1037.1% | 13.92% | 1.92% |
| Dept financing | 3% | 50% | 24% | 10% |
| Current Ratio | 12.91% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 12.91% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 11.45% | 0.29% | 0.88% | 1.14% |
| Liquididy | 75% | 4% | 9% | 14% |